67 related articles for article (PubMed ID: 20733371)
1. Optimum preservation for autologous cultured dermal substitutes.
Hayama Y; Ueda K; Kuroyanagi Y
Ann Plast Surg; 2010 Sep; 65(3):338-43. PubMed ID: 20733371
[TBL] [Abstract][Full Text] [Related]
2. The possibility of long-term cryopreservation of cultured dermal substitute.
Kubo K; Kuroyanagi Y
Artif Organs; 2005 Oct; 29(10):800-5. PubMed ID: 16185341
[TBL] [Abstract][Full Text] [Related]
3. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro.
Kubo K; Kuroyanagi Y
J Artif Organs; 2003; 6(4):267-72. PubMed ID: 14691669
[TBL] [Abstract][Full Text] [Related]
4. A study of cytokines released from fibroblasts in cultured dermal substitute.
Kubo K; Kuroyanagi Y
Artif Organs; 2005 Oct; 29(10):845-9. PubMed ID: 16185348
[TBL] [Abstract][Full Text] [Related]
5. Potential of a cryopreserved cultured dermal substitute composed of hyaluronic acid and collagen to release angiogenic cytokine.
Sawa M; Kuroyanagi Y
J Biomater Sci Polym Ed; 2013; 24(2):224-38. PubMed ID: 23565599
[TBL] [Abstract][Full Text] [Related]
6. Development of cultured dermal substitute composed of hyaluronic acid and collagen spongy sheet containing fibroblasts and epidermal growth factor.
Kuroyanagi M; Yamamoto A; Shimizu N; Ishihara E; Ohno H; Takeda A; Kuroyanagi Y
J Biomater Sci Polym Ed; 2014; 25(11):1133-43. PubMed ID: 24890602
[TBL] [Abstract][Full Text] [Related]
7. Harvesting and cryopreservation of lymphatic endothelial cells for lymphatic tissue engineering.
Jiang Z; Hu X; Kretlow JD; Liu N
Cryobiology; 2010 Apr; 60(2):177-83. PubMed ID: 19879864
[TBL] [Abstract][Full Text] [Related]
8. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation.
Kubo K; Kuroyanagi Y
Artif Organs; 2004 Feb; 28(2):182-8. PubMed ID: 14961958
[TBL] [Abstract][Full Text] [Related]
9. Establishment of banking system for allogeneic cultured dermal substitute.
Kuroyanagi Y; Kubo K; Matsui H; Kim HJ; Numari S; Mabuchi Y; Kagawa S
Artif Organs; 2004 Jan; 28(1):13-21. PubMed ID: 14720283
[TBL] [Abstract][Full Text] [Related]
10. Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation.
Lamme EN; Van Leeuwen RT; Brandsma K; Van Marle J; Middelkoop E
J Pathol; 2000 Apr; 190(5):595-603. PubMed ID: 10727986
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.
Moroi Y; Fujita S; Fukagawa S; Mashino T; Goto T; Masuda T; Urabe K; Kubo K; Matsui H; Kagawa S; Kuroyanagi Y; Furue M
Eur J Dermatol; 2004; 14(3):172-6. PubMed ID: 15246944
[TBL] [Abstract][Full Text] [Related]
12. New approach to improving endothelial preservation in cryopreserved arterial substitutes.
Pascual G; Rodríguez M; Corrales C; Turégano F; García-Honduvilla N; Bellón JM; Buján J
Cryobiology; 2004 Feb; 48(1):62-71. PubMed ID: 14969683
[TBL] [Abstract][Full Text] [Related]
13. Skin regeneration for children with burn scar contracture using autologous cultured dermal substitutes and superthin auto-skin grafts: preliminary clinical study.
Fujimori Y; Ueda K; Fumimoto H; Kubo K; Kuroyanagi Y
Ann Plast Surg; 2006 Oct; 57(4):408-14. PubMed ID: 16998333
[TBL] [Abstract][Full Text] [Related]
14. Endothelial network formed with human dermal microvascular endothelial cells in autologous multicellular skin substitutes.
Ponec M; El Ghalbzouri A; Dijkman R; Kempenaar J; van der Pluijm G; Koolwijk P
Angiogenesis; 2004; 7(4):295-305. PubMed ID: 15886873
[TBL] [Abstract][Full Text] [Related]
15. The suitability of cells from different tissues for use in tissue-engineered skin substitutes.
van den Bogaerdt AJ; van Zuijlen PP; van Galen M; Lamme EN; Middelkoop E
Arch Dermatol Res; 2002 May; 294(3):135-42. PubMed ID: 12029501
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
17. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute.
Kashiwa N; Ito O; Ueda T; Kubo K; Matsui H; Kuroyanagi Y
Artif Organs; 2004 May; 28(5):444-50. PubMed ID: 15113338
[TBL] [Abstract][Full Text] [Related]
18. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes.
Spiekstra SW; Breetveld M; Rustemeyer T; Scheper RJ; Gibbs S
Wound Repair Regen; 2007; 15(5):708-17. PubMed ID: 17971017
[TBL] [Abstract][Full Text] [Related]
19. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation.
Kubo K; Kuroyanagi Y
J Biomater Sci Polym Ed; 2003; 14(7):625-41. PubMed ID: 12903732
[TBL] [Abstract][Full Text] [Related]
20. A simple human dermal model for assessment of in vitro attachment efficiency of stored cultured epithelial autografts.
Ghosh MM; Boyce SG; Freedlander E; MacNeil S
J Burn Care Rehabil; 1995; 16(4):407-17. PubMed ID: 8582920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
